{"prompt": "['Synopsis', 'Title', 'Exercise in older women with breast cancer during systemic therapy - a', 'randomized controlled trial.', 'Introduction', 'Although cancer is predominantly a disease of the elderly, older cancer', 'patients are underrepresented in clinical trials. Aging itself is associated', 'with limitations in physical function, reduced reserve capacity, a poorer', 'resilience to physiological stressors, and an increased burden of', 'comorbidities. A diagnosis of cancer and its accompanying treatments can', 'lead to numerous symptoms and side effects, physical disability,', 'psychological distress and increased health care needs. The interplay', 'between age-related and cancer-related declines in health increases', 'vulnerability and the risk of development of short and long-term disability.', 'Research has shown that exercise training has several beneficial effects in', 'cancer patients and survivors both during and after anti-cancer treatment.', 'However, older patients have often been underrepresented in these studies,', 'and only few exercise-based intervention studies have specifically focused', 'on older cancer patients. Breast cancer is a malignancy associated with', 'aging. Research projects that investigate the effect of interventions that', 'may reduce symptoms, maintain physical function, and optimize QOL are', 'wanted.', 'The TOLCA Breast Cancer Exercise study will be conducted similar to the', 'ongoing PACE-MOBIL-PBL study regarding physical therapy.', 'Design', 'TOLCA Breast Cancer Exercise study is a two-armed 1:1 randomized', 'controlled study in older patients with breast cancer treated with adjuvant', 'or first-line palliative systemic therapy.', 'Target population', 'Older patients with breast cancer who are treated with adjuvant or first-line', 'palliative systemic therapy.', 'Number of Centers', 'Single center. Department of Oncology and Department of Occupational', 'and setting', 'Therapy and Physiotherapy, Herlev and Gentofte Hospital.', 'Objectives', 'To investigate the effect of an exercise-based intervention on physical', 'function and capacity, cancer-related symptoms and side-effects,', 'depression and anxiety, quality of life, body composition, treatment', 'tolerance and toxicity, inflammation, hospital admissions, and survival.', 'Selection Criteria', 'Inclusion criteria:', 'Be operated for primary breast cancer within 12 weeks or', 'Be diagnosed with locally advanced or metastatic breast cancer. Be', 'treated with adjuvant or first-line palliative therapy defined as', 'chemotherapy HER2 directed treatment, antihormonal treatment,', 'antihormonal treatment + HER 2, directed treatment CDK 4/6', 'inhibitor.', 'Be > 70 years of age at the time of signing the informed consent', 'form', 'Have an Eastern Cooperative Oncology Group (ECOG) performance', 'status score < 2', 'Be able to speak and read Danish, and to provide a signed informed', 'consent form', '4', 'Protocol TOLCA - Breast Cancer Exercise v8 18.06.2018']['Exclusion criteria; patients with:', 'Any physical condition that hinder the execution of physical exercise', 'training', 'Other types of cancer', 'Documented and uncontrolled brain metastases that hinder', 'participation in an exercise-based trial, based on the referring', \"oncologist's assessment\", 'Dementia, psychotic disorders, or other cognitive diseases or', 'conditions that hinder written consent', 'Unstable medical disease or history of serious or concurrent illness;', 'any medical condition that might be aggravated by exercise training', 'or that cannot be controlled, including, but not restricted congestive', 'heart failure (NYHA class III-IV), unstable angina pectoris,', 'implantable cardioverter defibrillator (ICD), or myocardial infarction', \"within 6 months, based on the referring oncologist's assessment\", 'In patients with documented bone metastases:', 'A bone metastatic burden or location that poses a risk of injury in the', 'performance of exercise training, as assessed by the referring', 'oncologist', 'Study arms', 'Included patients will be randomized 1:1 to an intervention group and a', 'control group.', 'Patients in the intervention group will receive standard care and a 12-week', 'exercise-based intervention comprised of:', '1. Supervised and group-based exercise training at the hospital setting', 'two times a week. Each session will last approximately 60 minutes', '2. Home-based walking with activity tracker assessment. Evaluation and', 'goal-setting in relation to activity (step counts) will be conducted once', 'weekly', '3. Serving of a protein supplement (protein drink or bar) after each', 'supervised training session', 'Patient in the control group will receive standard care.', 'Baseline data and', 'Baseline data', 'endpoints', 'Demographic and patient-reported data: data on civil status, working', 'status, education, smoking, alcohol consumption, weight loss before', 'and after cancer diagnosis, and physical activity', 'Clinical and medical data: diagnosis, treatment, performance status', '(ECOG), comorbidity, including Charlson comorbidity score.', 'End-points', 'Physical function and capacity: 30-second chair stand test (30s-CST)', '(primary outcome), 6-minute-walk-test (6MWT), hand grip strength', '(HST), 6- and 10-meter gait speed, measured at normal and maximal', 'gait speed (6MGS & 10MGS) and stair climb test (SCT).', 'Feasibility measures: recruitment rate, attrition, retention, and', 'adherence', 'Patient reported outcomes: patient reported performance status', '(ECOG), EORTC Quality of Life Questionnaire (EORTC-QLQ-C34', '5', 'Protocol TOLCA - Breast Cancer Exercise v8 18.06.2018']\n\n###\n\n", "completion": "END"}